This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated September 2026 quarter revenue down 28.2%; PAT positive
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 0.9 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated results for the quarter ended 30 September 2026 showed revenue from operations of Rs 2,182.89 lakh, down 28.2% from Rs 3,038.05 lakh a year earlier, and profit after tax of about Rs 50.72 lakh versus about Rs 109.1 lakh. The consolidated operating EBITDA margin fell to about 2.3% from 6.8%. Standalone half-year PAT was Rs 159.82 lakh, and standalone half-year operating cash flow was negative Rs 846.98 lakh.
Lower sales and margins may pressure the stock, though Q2 stayed profitable. Negative half-year operating cash flow raises funding concerns.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹21.83 Cr | ₹22.28 Cr | −2.0% |
| Operating profit | −₹1.64 Cr | −₹1.15 Cr | loss widened |
| Profit after tax | ₹0.51 Cr | −₹0.20 Cr | turned positive |
| EBITDA margin | 2.3% | 4.1% | −1.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.